PMID- 33304230 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20240330 IS - 1618-0240 (Print) IS - 1618-2863 (Electronic) IS - 1618-0240 (Linking) VI - 20 IP - 12 DP - 2020 Dec TI - Bcl-xL expression following articular cartilage injury and its effects on the biological function of chondrocytes. PG - 571-579 LID - 10.1002/elsc.202000039 [doi] AB - This study aimed to investigate the expression of B-cell lymphoma-extra large (Bcl-xL) in cartilage tissues following articular cartilage injury and to determine its effects on the biological function of chondrocytes. A total of 25 necrotic cartilage tissue samples and 25 normal tissue samples were collected from patients diagnosed with osteoarthritis at our hospital from December 2015 to December 2018. The mRNA expression levels of Bcl-xL, caspase-3, and matrix metalloproteinase-3 (MMP-3) in the normal and necrotic tissues were examined via quantitative polymerase chain reaction, and their protein expression levels were detected via western blotting. The expression levels of Bcl-xL, insulin-like growth factor-1 (IGF-1), and bone morphogenetic protein (BMP) were significantly lower but those of caspase-3, MMP-3, interleukin-1beta (IL-1beta), and chemokine-like factor 1 (CKLF1) levels were markedly higher in necrotic cartilage tissues than in normal tissues. Following cell transfection, the expression levels of Bcl-xL, IGF-1, and BMP were remarkably higher but those of caspase-3, MMP-3, IL-1beta, and CKLF1 were notably lower in the Si-Bcl-xL group than in the NC group. The Si-Bcl-xL group showed significantly lower cell growth and noticeably higher apoptosis rate than the NC group (normal control group). The expression of Bcl-xL is reduced following articular cartilage injury, and this reduction promotes the proliferation and inhibits the apoptosis of chondrocytes. Therefore, Bcl-xL could serve as a relevant molecular target in the clinical practice of osteoarthritis and other diseases causing cartilage damage. CI - (c) 2020 The Authors. Engineering in Life Sciences published by Wiley-VCH GmbH. FAU - Pan, Zhengjun AU - Pan Z AD - Orthopedics Department The First Affiliated Hospital of Anhui Medical University Hefei Anhui P. R. China. AD - Orthopedics Department The First People's Hospital of Hefei Hefei Anhui P. R. China. FAU - Yin, Hao AU - Yin H AD - Orthopedics Department The First People's Hospital of Hefei Hefei Anhui P. R. China. FAU - Wang, Shuangli AU - Wang S AD - Orthopedics Department The First People's Hospital of Hefei Hefei Anhui P. R. China. FAU - Xiong, Gaoxin AU - Xiong G AD - Orthopedics Department The First People's Hospital of Hefei Hefei Anhui P. R. China. FAU - Yin, Zongsheng AU - Yin Z AD - Orthopedics Department The First Affiliated Hospital of Anhui Medical University Hefei Anhui P. R. China. LA - eng PT - Journal Article DEP - 20201013 PL - Germany TA - Eng Life Sci JT - Engineering in life sciences JID - 101193313 PMC - PMC7708954 OTO - NOTNLM OT - BMP OT - Bcl-xL OT - CKLF1 OT - IGF-1 OT - IL-1beta OT - MMP-3 OT - cartilage damage OT - caspase-3 OT - osteoarthritis COIS- The autors have declared no conflict of interest. EDAT- 2020/12/12 06:00 MHDA- 2020/12/12 06:01 PMCR- 2020/10/13 CRDT- 2020/12/11 06:01 PHST- 2020/05/22 00:00 [received] PHST- 2020/09/08 00:00 [revised] PHST- 2020/09/14 00:00 [accepted] PHST- 2020/12/11 06:01 [entrez] PHST- 2020/12/12 06:00 [pubmed] PHST- 2020/12/12 06:01 [medline] PHST- 2020/10/13 00:00 [pmc-release] AID - ELSC1343 [pii] AID - 10.1002/elsc.202000039 [doi] PST - epublish SO - Eng Life Sci. 2020 Oct 13;20(12):571-579. doi: 10.1002/elsc.202000039. eCollection 2020 Dec.